Adenia Partners (“Adenia”), a leading private equity firm focused on growth opportunities in Africa, has signed definitive agreements to acquire a majority stake in Parkville Pharmaceuticals from Admaius Capital Partners (“Admaius”), a prominent Africa-focused private equity firm, alongside Dr. Sherif Bassiouny, Chairman of Parkville, and Dr. Mahmoud Farrag, CEO of Parkville. Parkville is a leading Egyptian healthcare and pharmaceutical company active in the pharmaceutical, cosmeceutical, and nutraceutical sectors. The transaction is subject to customary closing conditions and regulatory approvals. Financial terms were not disclosed.
Founded in 2008 and headquartered in Cairo, Parkville specializes in the development, manufacturing, and distribution of innovative products across a broad portfolio including skincare, haircare, deodorants, wellness, and therapeutic pharmaceutical lines. With a strong focus on research, quality, and community wellbeing, Parkville has grown rapidly to become a leading local champion in Egypt’s fast-growing cosmeceutical industry, outperforming many prominent local and international brands.
By partnering with the company’s founders and management, Adenia will support Parkville’s next phase of growth, focusing on product portfolio enhancement, digital and e-commerce acceleration, and expansion into regional markets. This first investment in Egypt aligns with Adenia’s mission to build high-performing, sustainable businesses across Africa.
Stéphane Bacquaert, Managing Partner, Adenia Partners, said: “We are delighted our first acquisition in Egypt is into one of the region’s fastest growing businesses. We see tremendous potential in Parkville’s mission to expand access to affordable, high-quality health and personal care products.”
Heba Hakky, Principal, Adenia Partners, said: “This investment reflects our conviction in Egypt’s long-term fundamentals and in the strength of locally built champions. We look forward to working closely with Parkville’s founders and management team in the next phase of its growth.”
Dr. Mahmoud Farrag, Co-Founder and CEO of Parkville Pharmaceuticals, said: “We are proud of the solid progress Parkville has achieved over the past two years in partnership with Admaius and our management team. This transformation has delivered a highly positive outcome for Admaius, translating into strong value creation. As we look ahead, we are excited to partner with Adenia to expand our product offering, strengthen our digital and commercial capabilities, and grow regionally. We remain deeply committed to serving our customers with excellence, fostering a healthy and empowering work environment for our people, and delivering sustainable, long-term value for our investors who believe in Parkville’s vision. Our ambition is to position Parkville as a Middle East and Africa champion.”
Adenia Partners was advised by Baker McKenzie as legal counsel. Zilla Capital acted as the sole financial advisor to the existing shareholders and Matouk Bassiouny served as legal counsel.
